{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:21:52Z","timestamp":1792725712634,"version":"4.5.0"},"reference-count":57,"publisher":"BMJ","issue":"11","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Br J Ophthalmol"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1136\/bjophthalmol-2017-310324","type":"journal-article","created":{"date-parts":[[2017,8,4]],"date-time":"2017-08-04T00:40:26Z","timestamp":1501807226000},"page":"1451-1460","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":48,"title":["Management of postoperative inflammation after cataract and complex ocular surgeries: a systematic review and Delphi survey"],"prefix":"10.1136","volume":"101","author":[{"given":"Florent","family":"Aptel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyrille","family":"Colin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sema","family":"Kaderli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Deloche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7265-931X","authenticated-orcid":false,"given":"Alain M","family":"Bron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Chiquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2017,8,3]]},"reference":[{"key":"key-10.1136\/bjophthalmol-2017-310324-1","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1001\/jama.290.2.248","article-title":"Recent advances and future frontiers in treating age-related cataracts","volume":"290","author":"Solomon","year":"2003","journal-title":"JAMA"},{"key":"key-10.1136\/bjophthalmol-2017-310324-2","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1136\/bjo.86.8.847","article-title":"Eye healthcare services in Eastern Europe: part 1. cataract surgery","volume":"86","author":"Kocur","year":"2002","journal-title":"Br J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2017-310324-3","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1136\/bjo.86.8.851","article-title":"Eye healthcare services in Eastern Europe: part 2. Vitreoretinal Surgical services","volume":"86","author":"Kocur","year":"2002","journal-title":"Br J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2017-310324-4","volume-title":"Eye Health Statistics","author":"AAO"},{"key":"key-10.1136\/bjophthalmol-2017-310324-5","volume-title":"control of major blinding diseases and disorders","author":"Blindness: Vision","year":"2020"},{"key":"key-10.1136\/bjophthalmol-2017-310324-6","volume-title":"Surgical operations and procedures statistics","author":"Eurostat","year":"2016"},{"key":"key-10.1136\/bjophthalmol-2017-310324-7","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0039-6257(92)90073-3","article-title":"Posterior capsule opacification","volume":"37","author":"Apple","year":"1992","journal-title":"Surv Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2017-310324-8","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/S0161-6420(89)32746-1","article-title":"Pupillary fibrin membrane. A frequent early complication after posterior chamber Lens implantation in Japan","volume":"96","author":"Miyake","year":"1989","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2017-310324-9","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1001\/archopht.1988.01060130810028","article-title":"Angiographic cystoid macular edema after posterior chamber Lens implantation","volume":"106","author":"Wright","year":"1988","journal-title":"Arch Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2017-310324-10","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1007\/s00417-013-2464-7","article-title":"Global rates of Glaucoma surgery","volume":"251","author":"Mansouri","year":"2013","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2017-310324-11","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/archophthalmol.2010.224","article-title":"Use of retinal procedures in medicare beneficiaries from 1997 to 2007","volume":"128","author":"Ramulu","year":"2010","journal-title":"Arch Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2017-310324-12","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1136\/bjo.2009.176495","article-title":"Sutureless vitrectomy: evolution and current practices","volume":"95","author":"Fabian","year":"2011","journal-title":"Br J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2017-310324-13","first-page":"189","article-title":"Minimally invasive Glaucoma surgery: current status and future prospects","volume":"10","author":"Richter","year":"2016","journal-title":"Clin Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2017-310324-14","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/ICU.0b013e3282f30577","article-title":"Perioperative antibiotics and anti-inflammatory agents in cataract surgery","volume":"19","author":"DeCroos","year":"2008","journal-title":"Curr Opin Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2017-310324-15","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3109\/09273948.2011.592260","article-title":"Survey of expert practice and perceptions of the supporting clinical evidence for the management of uveitis-related cataract and cystoid macular oedema","volume":"19","author":"Sreekantam","year":"2011","journal-title":"Ocul Immunol Inflamm"},{"key":"key-10.1136\/bjophthalmol-2017-310324-16","first-page":"1281","article-title":"Management of mydriasis and pain in cataract and intraocular Lens surgery: review of current medications and future directions","volume":"8","author":"Grob","year":"2014","journal-title":"Clin Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2017-310324-17","unstructured":"Current use of non-steroidal anti-inflammatory drugs in the treatment of ocular inflammation related to cataract surgery. http:\/\/www.touchophthalmology.com\/articles\/current-use-non-steroidal-anti-inflammatory-drugs-treatment-ocular-inflammation-related-cat. accessed 24 sep 2016."},{"key":"key-10.1136\/bjophthalmol-2017-310324-18","article-title":"Preferred practice pattern guidelines","author":"American academy of ophthalmology cataract and anterior segment panel","journal-title":"Cataract in the adult eye. American Academy of Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2017-310324-19","article-title":"Statistical review and evaluation: bromfenac ophthalmic solutions, 0.075%","author":"InSiteVisionsInc","journal-title":"FDA office of biostatistics;NDA"},{"key":"key-10.1136\/bjophthalmol-2017-310324-20","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1016\/S0161-6420(98)99054-6","article-title":"The loteprednol etabonate postoperative inflammation study group 2. A double-masked, placebo-controlled evaluation of 0.5% loteprednol etabonate in the treatment of postoperative inflammation","volume":"105","year":"1998","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2017-310324-21","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.ajo.2010.09.003","article-title":"Twice-daily, preservative-free ketorolac 0.45% for treatment of inflammation and pain after cataract surgery","volume":"151","author":"Donnenfeld","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2017-310324-22","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jcrs.2006.08.043","article-title":"Nepafenac ophthalmic suspension 0.1% for the prevention and treatment of ocular inflammation associated with cataract surgery","volume":"33","author":"Lane","year":"2007","journal-title":"J Cataract Refract Surg"},{"key":"key-10.1136\/bjophthalmol-2017-310324-23","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jcrs.2013.07.042","article-title":"Once-daily nepafenac ophthalmic suspension 0.3% to prevent and treat ocular inflammation and pain after cataract surgery: phase 3 study","volume":"40","author":"Modi","year":"2014","journal-title":"J Cataract Refract Surg"},{"key":"key-10.1136\/bjophthalmol-2017-310324-24","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ophtha.2013.07.006","article-title":"Bromfenac ophthalmic solution 0.07% dosed once daily for cataract surgery: results of 2 randomized controlled trials","volume":"121","author":"Walters","year":"2014","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2017-310324-25","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1185\/03007995.2011.597663","article-title":"Once daily dosing of bromfenac ophthalmic solution 0.09% for postoperative ocular inflammation and pain","volume":"27","author":"Silverstein","year":"2011","journal-title":"Curr Med Res Opin"},{"key":"key-10.1136\/bjophthalmol-2017-310324-26","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1016\/j.ophtha.2011.04.035","article-title":"Safety and efficacy of bromfenac ophthalmic solution (Bromday) dosed once daily for postoperative ocular inflammation and pain","volume":"118","author":"Henderson","year":"2011","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2017-310324-27","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.2147\/OPTH.S32643","article-title":"Loteprednol etabonate gel 0.5% for postoperative pain and inflammation after cataract surgery: results of a multicenter trial","volume":"6","author":"Fong","year":"2012","journal-title":"Clin Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2017-310324-28","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jcrs.2012.09.013","article-title":"Efficacy and safety of loteprednol etabonate 0.5% gel in the treatment of ocular inflammation and pain after cataract surgery","volume":"39","author":"Rajpal","year":"2013","journal-title":"J Cataract Refract Surg"},{"key":"key-10.1136\/bjophthalmol-2017-310324-29","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jcrs.2008.09.024","article-title":"Difluprednate ophthalmic emulsion 0.05% for postoperative inflammation and pain","volume":"35","author":"Korenfeld","year":"2009","journal-title":"J Cataract Refract Surg"},{"key":"key-10.1136\/bjophthalmol-2017-310324-30","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0886-3350(13)80611-6","article-title":"Flurbiprofen 0.03% for the control of inflammation following cataract extraction by phacoemulsification","volume":"19","author":"Blaydes","year":"1993","journal-title":"J Cataract Refract Surg"},{"key":"key-10.1136\/bjophthalmol-2017-310324-31","unstructured":"EMEA. Nevanac clinical trial C04.65. Secondary Nevanac clinical trial C04. 2007. 65 [Scientific discussion] http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Scientific_Discussion\/human\/000818\/WC500027155.pdf."},{"key":"key-10.1136\/bjophthalmol-2017-310324-32","unstructured":"CDER. Bromfenac Medical Review clinical trial S00124WR and ER secondary Bromfenac Medical Review clinical trial S00124WR and ER [Clinical review]. 2013 http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2013\/203168Orig1s000MedR.pdf."},{"key":"key-10.1136\/bjophthalmol-2017-310324-33","unstructured":"CDER. Difluprednate Medical Review clinical trial 002A & 002B. secondary Difluprednate Medical Review clinical trial 002A & 002B. 2008 http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2008\/022212s000_MedR.pdf."},{"key":"key-10.1136\/bjophthalmol-2017-310324-34","unstructured":"CDER. Bromfenac Medical Review clinical trial ISTABR-CS001-ER and WR. secondary Bromfenac Medical Review clinical trial ISTABR-CS001-ER and WR [Medical review]. 2005 http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2005\/021664s000_MedR.pdf."},{"key":"key-10.1136\/bjophthalmol-2017-310324-35","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1136\/bmj.311.7001.376","article-title":"Consensus methods for medical and health services research","volume":"311","author":"Jones","year":"1995","journal-title":"BMJ"},{"key":"key-10.1136\/bjophthalmol-2017-310324-36","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1108\/09654280310459112","article-title":"The Delphi method and health research","volume":"103","author":"de Meyrick","year":"2003","journal-title":"Health Educ"},{"key":"key-10.1136\/bjophthalmol-2017-310324-37","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Standardization of uveitis nomenclature for reporting clinical data. results of the First International Workshop","volume":"140","author":"Jabs","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2017-310324-38","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/j.jcrs.2011.03.049","article-title":"Single perioperative subconjunctival steroid depot versus postoperative steroid eyedrops to prevent intraocular inflammation and macular edema after cataract surgery","volume":"37","author":"Dieleman","year":"2011","journal-title":"J Cataract Refract Surg"},{"key":"key-10.1136\/bjophthalmol-2017-310324-39","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jcrs.2003.08.028","article-title":"Safety and efficacy of a dexamethasone anterior segment drug delivery system in patients after phacoemulsification","volume":"30","author":"Wadood","year":"2004","journal-title":"J Cataract Refract Surg"},{"key":"key-10.1136\/bjophthalmol-2017-310324-40","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0161-6420(99)90060-X","article-title":"Randomized clinical trial of a new dexamethasone delivery system (Surodex) for treatment of post-cataract surgery inflammation","volume":"106","author":"Tan","year":"1999","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2017-310324-41","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1016\/S0161-6420(01)00839-9","article-title":"Randomized clinical trial of Surodex steroid drug delivery system for cataract surgery: anterior versus posterior placement of two Surodex in the eye","volume":"108","author":"Tan","year":"2001","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2017-310324-42","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1001\/archopht.1995.01100060051031","article-title":"A comparison of topical diclofenac with prednisolone for postcataract inflammation","volume":"113","author":"Roberts","year":"1995","journal-title":"Arch Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2017-310324-43","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jcrs.2005.12.102","article-title":"Single perioperative triamcinolone injection versus standard postoperative steroid drops after uneventful phacoemulsification surgery: randomized controlled trial","volume":"32","author":"Negi","year":"2006","journal-title":"J Cataract Refract Surg"},{"key":"key-10.1136\/bjophthalmol-2017-310324-44","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.jcrs.2013.11.043","article-title":"Intraindividual aqueous flare comparison after implantation of hydrophobic intraocular lenses with or without a heparin-coated surface","volume":"40","author":"Krall","year":"2014","journal-title":"J Cataract Refract Surg"},{"key":"key-10.1136\/bjophthalmol-2017-310324-45","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0886-3350(01)01077-X","article-title":"Naproxen ophthalmic solution to manage inflammation after phacoemulsification","volume":"28","author":"Papa","year":"2002","journal-title":"J Cataract Refract Surg"},{"key":"key-10.1136\/bjophthalmol-2017-310324-46","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1111\/j.1755-3768.2012.02520.x","article-title":"Efficacy and safety of indomethacin 0.1% eye drops compared with ketorolac 0.5% eye drops in the management of ocular inflammation after cataract surgery","volume":"91","author":"Weber","year":"2013","journal-title":"Acta Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2017-310324-47","doi-asserted-by":"crossref","first-page":"150","DOI":"10.4103\/0974-620X.192268","article-title":"A comparative study of various topical nonsteroidal anti-inflammatory drugs to steroid drops for control of post cataract surgery inflammation","volume":"9","author":"Malik","year":"2016","journal-title":"Oman J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2017-310324-48","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/j.jcrs.2013.04.042","article-title":"Efficacy and safety of intracameral triamcinolone acetonide to control postoperative inflammation after phacotrabeculectomy","volume":"39","author":"Wang","year":"2013","journal-title":"J Cataract Refract Surg"},{"key":"key-10.1136\/bjophthalmol-2017-310324-49","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1001\/archopht.126.9.1203","article-title":"Topical ketorolac in vitreoretinal surgery: a prospective, randomized, placebo-controlled, double-masked trial","volume":"126","author":"Kim","year":"2008","journal-title":"Arch Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2017-310324-50","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s10792-015-0168-1","article-title":"Comparative effect of topical diclofenac and topical dexamethasone on anterior chamber flare and postoperative pain following rhegmatogenous retinal detachment surgery","volume":"36","author":"Ben Yahia","year":"2016","journal-title":"Int Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2017-310324-51","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1097\/IAE.0b013e3181b094e6","article-title":"Vitreous nonsteroidal antiinflammatory drug concentrations and prostaglandin E2 levels in vitrectomy patients treated with ketorolac 0.4%, bromfenac 0.09%, and nepafenac 0.1%","volume":"29","author":"Heier","year":"2009","journal-title":"Retina"},{"key":"key-10.1136\/bjophthalmol-2017-310324-52","first-page":"845","article-title":"The influence of subconjunctival depot corticosteroid on choroidal detachment following retinal detachment surgery","volume":"79","author":"Burton","year":"1975","journal-title":"Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol"},{"key":"key-10.1136\/bjophthalmol-2017-310324-53","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3928\/1542-8877-20030501-04","article-title":"Intravitreal dexamethasone effectively reduces postoperative inflammation after vitreoretinal surgery","volume":"34","author":"Chalam","year":"2003","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"key-10.1136\/bjophthalmol-2017-310324-54","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1097\/IAE.0b013e31817d5be3","article-title":"Intravitreal triamcinolone acetonide injection at the end of vitrectomy for diabetic vitreous hemorrhage: a randomized, clinical trial","volume":"28","author":"Faghihi","year":"2008","journal-title":"Retina"},{"key":"key-10.1136\/bjophthalmol-2017-310324-55","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/00003226-200307000-00005","article-title":"Long-term observation of aqueous flare following penetrating keratoplasty","volume":"22","author":"Ma","year":"2003","journal-title":"Cornea"},{"key":"key-10.1136\/bjophthalmol-2017-310324-56","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.ajo.2008.10.009","article-title":"Comparison of one-year outcomes between 23- and 20-gauge vitrectomy for preretinal membrane","volume":"147","author":"Hikichi","year":"2009","journal-title":"Am J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2017-310324-57","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1097\/IAE.0b013e3182456f38","article-title":"Time course of changes in aqueous flare intensity after vitrectomy for rhegmatogenous retinal detachment","volume":"32","author":"Hoshi","year":"2012","journal-title":"Retina"}],"container-title":["British Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjophthalmol-2017-310324","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T08:55:10Z","timestamp":1601110510000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjo.bmj.com\/lookup\/doi\/10.1136\/bjophthalmol-2017-310324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,3]]},"references-count":57,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2017,10,25]]},"published-print":{"date-parts":[[2017,11]]}},"alternative-id":["10.1136\/bjophthalmol-2017-310324"],"URL":"https:\/\/doi.org\/10.1136\/bjophthalmol-2017-310324","relation":{},"ISSN":["0007-1161","1468-2079"],"issn-type":[{"value":"0007-1161","type":"print"},{"value":"1468-2079","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,3]]}}}